UNIVERSITY OF CINCINNATI
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1819-01-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- https://www.uc.edu/
Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients
Phase 4
Completed
- Conditions
- Complication of Transplant
- Interventions
- Drug: Tacrolimus, SandozDrug: Tacrolimus, Reddy LaboratoryDrug: Tacrolimus, MylanDrug: Tacrolimus, AccordDrug: Tacrolimus, Pancea Biotech Limited
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 71
- Registration Number
- NCT02014103
- Locations
- 🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Phase 2
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Radiation: Radiation Therapy
- First Posted Date
- 2013-11-08
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 24
- Registration Number
- NCT01979211
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
High Intensity Interval Training in Chronic Stroke
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Other: High-intensity interval training (HIT)Other: Traditional Aerobic Training
- First Posted Date
- 2013-10-09
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 18
- Registration Number
- NCT01958606
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
Clinician Ability to Predict the Presence of Nosocomial Pneumonia Based on Bronchoscopic Findings
Completed
- Conditions
- Pneumonia
- First Posted Date
- 2013-07-22
- Last Posted Date
- 2013-07-22
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 30
- Registration Number
- NCT01904305
- Locations
- 🇺🇸
University Hospital, Cincinnati, Ohio, United States
Pharmacokinetic Studies of Tacrolimus in Transplant Patients
Phase 4
Completed
- Conditions
- Kidney Transplant RecipientsLiver Transplant Recipients
- Interventions
- First Posted Date
- 2013-06-28
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 78
- Registration Number
- NCT01889758
- Locations
- 🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States
🇺🇸University of Cincinnati, Cincinnati, Ohio, United States
Retraining Attention to Treat Alcohol Dependence and Social Anxiety
Not Applicable
Completed
- Conditions
- Alcohol DrinkingAnxiety Disorders
- Interventions
- Behavioral: Anxiety Attention TrainingBehavioral: Control TrainingBehavioral: Alcohol Attention Training
- First Posted Date
- 2013-06-26
- Last Posted Date
- 2016-12-28
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 115
- Registration Number
- NCT01886716
- Locations
- 🇺🇸
University of Cincinnati Department of Family and Community Medicine, Cincinnati, Ohio, United States
Effect of Omega-3 Fatty Acid on Cortical Function in ADHD
- First Posted Date
- 2013-06-21
- Last Posted Date
- 2022-03-16
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 30
- Registration Number
- NCT01883817
- Locations
- 🇺🇸
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, Cincinnati, Ohio, United States
SGA-induced Metabolic Syndrome in Bipolar Youth
Phase 3
Completed
- Conditions
- Bipolar Youth Treated With Second-generation Antipsychotics
- Interventions
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2022-11-25
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 19
- Registration Number
- NCT01858948
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)
- First Posted Date
- 2013-04-12
- Last Posted Date
- 2015-12-08
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 50
- Registration Number
- NCT01830959
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure
Phase 2
Completed
- Conditions
- Systolic Heart Failure
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-03-19
- Last Posted Date
- 2015-08-26
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 20
- Registration Number
- NCT01814319
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath